Hypoxia induced deregulation of sphingolipids in colon cancer is a prognostic marker for patient outcome-Reference-Cited by-同舟云学术

Hypoxia induced deregulation of sphingolipids in colon cancer is a prognostic marker for patient outcome

Published:2024-01 Issue:1 Volume:1870 Page:166906
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

El Hindi Khadija,Brachtendorf Sebastian,Hartel Jennifer C.,Renné Christoph,Birod Kerstin,Schilling Karin,Labocha Sandra,Thomas Dominique,Ferreirós Nerea,Hahnefeld Lisa,Dorochow Erika,Del Turco Domenico,Deller Thomas,Scholich Klaus,Fuhrmann Dominik C.,Weigert Andreas,Brüne Bernhard,Geisslinger Gerd,Wittig Ilka,Link Karl-Heinrich,Grösch Sabine

Funder

Deutsche Forschungsgemeinschaft

Fraunhofer Cluster of Excellence Immune-Mediated Diseases

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference87 articles.

1. Colon cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study;White;Cancer,2017

2. A genetic model for colorectal tumorigenesis;Fearon;Cell,1990

3. Colorectal Adenomas;Strum;N. Engl. J. Med.,2016

4. The consensus molecular subtypes of colorectal cancer;Guinney;Nat. Med.,2015

5. Molecular-subtype-specific biomarkers improve prediction of prognosis in colorectal Cancer;Bramsen;Cell Rep.,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Utility of Lipidomic Analysis in Colorectal Cancer Diagnosis and Prognosis—A Systematic Review of Recent Literature;International Journal of Molecular Sciences;2024-07-14

2. How ceramides affect the development of colon cancer: from normal colon to carcinoma;Pflügers Archiv - European Journal of Physiology;2024-04-18

3. Advances in Precision Medicine Approaches for Colorectal Cancer: From Molecular Profiling to Targeted Therapies;ACS Pharmacology & Translational Science;2024-03-19

4. pH-Sensitive Nanoparticles of Epigallocatechin-3-Gallate in Enhanced Colorectal Cancer Therapy;Nanomedicine;2024-01-15